Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome
Stopped Inclusion stopped at 50% after interim analysis: primary efficacy endpoint not significant
Conditions
- Covid19
- SARS-CoV Infection
Interventions
- PROCEDURE: Auricular neuromodulation
- PROCEDURE: Control
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild